Cargando…

Evidence‐Based Development and Clinical Use of Precision Oncology Therapeutics

Detalles Bibliográficos
Autores principales:	Comment, Leah A., Ward, Ashley F., Schrock, Alexa B., Fabrizio, David, Venstrom, Jeffrey M., Hegde, Priti S., Alexander, Brian M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485138/ https://www.ncbi.nlm.nih.gov/pubmed/32744335 http://dx.doi.org/10.1002/cpt.1967

Ejemplares similares

Giving Up on Precision Oncology? Not So Fast!
por: Warner, JL
Publicado: (2017)

A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada
por: Regier, Dean A., et al.
Publicado: (2022)

Artificial intelligence for precision oncology: beyond patient stratification
por: Azuaje, Francisco
Publicado: (2019)

Precision oncology: Charting a path forward to broader deployment of genomic profiling
por: Schram, Alison M., et al.
Publicado: (2017)

Precision oncology for patients with advanced cancer: the challenges of malignant snowflakes
por: Kurzrock, Razelle, et al.
Publicado: (2015)

Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?
por: Sant, Grannum R., et al.
Publicado: (2017)

Circulating free DNA in the era of precision oncology: Pre- and post-analytical concerns
por: Lu, Jun-Liang, et al.
Publicado: (2016)

Artificial intelligence ethics in precision oncology: balancing advancements in technology with patient privacy and autonomy
por: Farasati Far, Bahareh
Publicado: (2023)

Precision antimicrobial therapeutics: the path of least resistance?
por: Spaulding, Caitlin N., et al.
Publicado: (2018)

Data Sharing, Clinical Trials, and Biomarkers in Precision Oncology: Challenges, Opportunities, and Programs at the Department of Veterans Affairs
por: Fiore, LD, et al.
Publicado: (2017)

How can we deliver on the promise of precision medicine in oncology and beyond? A practical roadmap for action
por: Baird, Anne‐Marie, et al.
Publicado: (2023)

Towards precision oncology in angiosarcomas using next generation “omic” technologies
por: Tan, Grace Fangmin, et al.
Publicado: (2021)

New evidence-based adaptive clinical trial methods for optimally integrating predictive biomarkers into oncology clinical development programs
por: Beckman, Robert A., et al.
Publicado: (2013)

Evolution of Next Generation Therapeutics: Past, Present, and Future of Precision Medicines
por: Ramamoorthy, Anuradha, et al.
Publicado: (2019)

Quantitative Translation in Immuno‐Oncology Research and Development
por: Bottino, Dean, et al.
Publicado: (2020)

Lights and Shadows in Immuno-Oncology Drug Development
por: Bergamino Sirvén, Milana, et al.
Publicado: (2021)

Rare versus common diseases: a false dichotomy in precision medicine
por: Chung, Brian Hon Yin, et al.
Publicado: (2021)

Multiplex bioimaging of single-cell spatial profiles for precision cancer diagnostics and therapeutics
por: Allam, Mayar, et al.
Publicado: (2020)

Precision Oncology—The Quest for Evidence
por: Soldatos, Theodoros G., et al.
Publicado: (2019)

Evidence-based medicine and precision medicine: Complementary approaches to clinical decision-making
por: Chow, Ngai, et al.
Publicado: (2018)

Oncology-Led Early Identification of Nutritional Risk: A Pragmatic, Evidence-Based Protocol (PRONTO)
por: Muscaritoli, Maurizio, et al.
Publicado: (2023)

Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT)
por: Normanno, Nicola, et al.
Publicado: (2020)

Derivation of a Precise and Consistent Timeline for Antibiotic Development
por: Stennett, Henry L., et al.
Publicado: (2022)

Precision oncogenomics in pediatrics: a personal reflection
por: Campbell, Cindy, et al.
Publicado: (2018)

mRNA vaccine development for cholangiocarcinoma: a precise pipeline
por: Tang, Tian-Yu, et al.
Publicado: (2022)

Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals
por: Fasola, Gianpiero, et al.
Publicado: (2023)

Study design considerations to assess the impact of potential drug–drug interactions in first‐in‐human studies in oncology drug development
por: Subramaniam, Sriram, et al.
Publicado: (2023)

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
por: Desai, Aakash, et al.
Publicado: (2021)

Real-world evidence to guide healthcare policies in oncology
por: Donia, Marco, et al.
Publicado: (2019)

A Novel Diagnostic and Therapeutic Strategy for Cancer Patients by Integrating Chinese Medicine Syndrome Differentiation and Precision Medicine
por: Yu, Shu-xian, et al.
Publicado: (2022)

Cardio-Oncology in Israel: Development and Future
por: Iakobishvili, Zaza, et al.
Publicado: (2019)

Characterization of Non–Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment Patterns
por: Lee, Jessica K., et al.
Publicado: (2021)

The implications of pharmacogenomics in oncology
por: Latimer, Jean J.
Publicado: (2023)

Precision medicine: affording the successes of science
por: Lu, Christine Y., et al.
Publicado: (2023)

Community-driven development of a modified progression-free survival ratio for precision oncology
por: Mock, Andreas, et al.
Publicado: (2019)

Development of management strategies for immune-related adverse effects of immunotherapies used in oncological treatment
por: Shankar, Abhishek, et al.
Publicado: (2021)

The role of precision medicine in interstitial lung disease
por: Maher, Toby M., et al.
Publicado: (2022)

Association of CD274 (PD-L1) Copy Number Changes with Immune Checkpoint Inhibitor Clinical Benefit in Non-Squamous Non-Small Cell Lung Cancer
por: Murugesan, Karthikeyan, et al.
Publicado: (2022)

A role for microfluidic systems in precision medicine
por: Ayuso, Jose M., et al.
Publicado: (2022)

Real-World Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologics License Application Approvals from 2015–2020
por: Arondekar, Bhakti, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5mlf392q4ptdej38ujcorvs1m8